Year-over-year net earnings per share growth for the last 12 months: Milestone Pharmaceuticals, Inc. (MIST)

Corporate emblem and logo of Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals (MIST) is automating patient telemetry collection via cloud IT solutions to accelerate clinical trials. The quarterly EPS growth profile helps assess the efficiency of these processes, where -5.80 characterizes this valuation parameter. The company is implementing the Etripamil nasal spray for self-administered tachycardia termination, expanding its presence in the over-the-counter emergency cardiology segment through innovative self-administration methods.

Milestone Pharmaceuticals Inc. (MIST) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 11/13/2026

Analytical breakdowns for Milestone Pharmaceuticals

- market value and analyst target forecast:
Price Chart Milestone Pharmaceuticals Inc.|MIST - Analyst Median Target
- company stock exchange capitalization indicators:
Market Valuation Milestone Pharma|MIST - Aggregate Business Value
- book capitalization indicators:
Net Assets per Single Share Milestone Pharmaceuticals|MIST - Total Stockholders' Equity|Market Value to Book Value Ratio milestonepharma.com|MIST - Total Business Assets
- company total debt and liquidity indicators:
Total Debt to Capital Milestone Pharmaceuticals|MIST - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Milestone Pharmaceuticals|MIST - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Milestone Pharma|MIST - Long-Term Liabilities|Company Short-Term Debts Milestone Pharmaceuticals|Quick Ratio milestonepharma.com
- earnings and market multiples details:
MIST - Net Profit|Expected Profit Milestone Pharmaceuticals|MIST - Company Value to Net Income|Future Price to Earnings Milestone Pharma|MIST - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Milestone Pharma|MIST - Operating profit EBITDA|Net earnings per share (EPS TTM) Milestone Pharmaceuticals|MIST - Net earnings per share for the last 12 months|Quarterly EPS earnings growth milestonepharma.com|MIST - Earnings per share growth rate in current year|Expected earnings per share growth for next year Milestone Pharmaceuticals
- sales volume and revenue indicators:
MIST - Revenue and Sales Volume
Summary company analytics:Milestone Pharmaceuticals
Flagship merchandise of milestonepharma.com

A portfolio analyst utilizes this tool to filter for fundamental leaders within the biopharmaceutical sector. The metric measures the percentage change in net earnings per share between the current and previous quarters. For Milestone Pharmaceuticals (MIST), this growth reflects the efficiency of its expansion into the emergency arrhythmia care segment. GURU.Markets investors should correlate the quarterly EPS growth vector with the issuer's debt obligations. Positive momentum confirms the commercial success of the innovative drugs.

Competing companies

Regeneron (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months LNTH|MLYS (Mineralys Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months HeartFlow (HTFL)|KMTS - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Esperion ESPR|AMRN: Year-over-year earnings per share growth for the last 12 months|Anteris Technologies Ltd - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Tenaya Therapeutics|CVRX (CVRx, Inc.) - Year-over-year net earnings per share growth for the last 12 months|Cardiol Therapeutics Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HeartBeam|Tenax Therapeutics Inc. - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ADGM|BCDA (BioCardia Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth VTAK (Catheter Precision)|Quarterly EPS earnings growth ARCA Biopharma Inc ABIO|ACST - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months AVTE (Aerovate Therapeutics Inc.)|vervetx.com (VERV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Windtree Therapeutics, Inc.